AAAAAA
Results: 1-25/37
Authors:
SCHWARZER S
REIBEL S
LANG AB
STRUCK MM
FINKEL B
GERIKE E
TISCHER A
GASSNER M
GLUCK R
STUCK B
CRYZ SJ
Citation: S. Schwarzer et al., SAFETY AND CHARACTERIZATION OF THE IMMUNE-RESPONSE ENGENDERED BY 2 COMBINED MEASLES, MUMPS AND RUBELLA VACCINES, Vaccine, 16(2-3), 1998, pp. 298-304
Authors:
FRYAUFF DJ
CRYZ SJ
WIDJAJA H
MOUZIN E
CHURCH LWP
SUTAMIHARDJA MA
RICHARDS AL
SUBIANTO B
HOFFMAN SL
Citation: Dj. Fryauff et al., HUMORAL IMMUNE-RESPONSE TO TETANUS-DIPHTHERIA VACCINE GIVEN DURING EXTENDED USE OF CHLOROQUINE OR PRIMAQUINE MALARIA CHEMOPROPHYLAXIS, The Journal of infectious diseases, 177(6), 1998, pp. 1762-1765
Authors:
CONNE P
GAUTHEY L
VERNET P
ALTHAUS B
QUE JU
FINKEL B
GLUCK R
CRYZ SJ
Citation: P. Conne et al., IMMUNOGENICITY OF TRIVALENT SUBUNIT VERSUS VIROSOME-FORMULATED INFLUENZA VACCINES IN GERIATRIC-PATIENTS, Vaccine, 15(15), 1997, pp. 1675-1679
Authors:
HERZOG C
WEGMULLER B
CRYZ SJ
Citation: C. Herzog et al., LIVE ORAL CHOLERA VACCINE, Lancet, 349(9067), 1997, pp. 1772-1773
Authors:
KOLLARITSCH H
QUE JU
KUNZ C
WIEDERMANN G
HERZOG C
CRYZ SJ
Citation: H. Kollaritsch et al., SAFETY AND IMMUNOGENICITY OF LIVE ORAL CHOLERA AND TYPHOID VACCINES ADMINISTERED ALONE OR IN COMBINATION WITH ANTIMALARIAL-DRUGS, ORAL POLIO VACCINE, OR YELLOW-FEVER VACCINE, The Journal of infectious diseases, 175(4), 1997, pp. 871-875
Authors:
TAYLOR DN
TACKET CO
LOSONSKY G
CASTRO O
GUTIERREZ J
MEZA R
NATARO JP
KAPER JB
WASSERMAN SS
EDELMAN R
LEVINE MM
CRYZ SJ
Citation: Dn. Taylor et al., EVALUATION OF A BIVALENT (CVD-103-HGR CVD-111) LIVE ORAL CHOLERA VACCINE IN ADULT VOLUNTEERS FROM THE UNITED-STATES AND PERU, Infection and immunity, 65(9), 1997, pp. 3852-3856
Authors:
VIRET JF
CRYZ SJ
FAVRE D
Citation: Jf. Viret et al., EXPRESSION OF SHIGELLA-SONNEI LIPOPOLYSACCHARIDE IN VIBRIO-CHOLERAE, Molecular microbiology, 19(5), 1996, pp. 949-963
Authors:
SHERWOOD JA
COPELAND RS
TAYLOR KA
ABOK K
OLOO AJ
WERE JBO
STRICKLAND GT
GORDON DM
BALLOU WR
BALES JD
WIRTZ RA
WITTES J
GROSS M
QUE JU
CRYZ SJ
OSTER CN
ROBERTS CR
SADOFF JC
Citation: Ja. Sherwood et al., PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE VACCINE IMMUNOGENICITY AND EFFICACY TRIAL WITH NATURAL CHALLENGE QUANTITATION IN AN AREA OF ENDEMIC HUMAN MALARIA OF KENYA, Vaccine, 14(8), 1996, pp. 817-827
Authors:
BRIGGS DJ
DREESEN DW
MORGAN P
CHIN JE
SEEDLE CD
CRYZ L
GLUCK R
CRYZ SJ
Citation: Dj. Briggs et al., SAFETY AND IMMUNOGENICITY OF LYSSAVAC BERNA HUMAN-DIPLOID CELL RABIESVACCINE IN HEALTHY-ADULTS, Vaccine, 14(14), 1996, pp. 1361-1365
Authors:
CRYZ SJ
QUE JU
GLUCK R
Citation: Sj. Cryz et al., A VIROSOME VACCINE ANTIGEN DELIVERY SYSTEM DOES NOT STIMULATE AN ANTIPHOSPHOLIPID ANTIBODY-RESPONSE IN HUMANS, Vaccine, 14(14), 1996, pp. 1381-1383
Authors:
DONTA ST
PEDUZZI P
CROSS AS
SADOFF J
HAAKENSON C
CRYZ SJ
KAUFFMAN C
BRADLEY S
GAFFORD G
ELLISTON D
BEAM TR
JOHN JF
RIBNER B
CANTEY R
WELSH CH
ELLISON RT
YOUNG EJ
HAMILL RJ
LEAF H
SCHEIN RMH
MULLIGAN M
JOHNSON C
ABRUTYN E
GRIFFISS JM
HAMADEH R
ELIASSON AH
MCCLAIN JB
MELCHER GP
KELLY JW
BYRNE WR
WALLACE M
AMUNDSON D
GUMPERT B
SLAGLE D
Citation: St. Donta et al., IMMUNOPROPHYLAXIS AGAINST KLEBSIELLA AND PSEUDOMONAS-AERUGINOSA INFECTIONS, The Journal of infectious diseases, 174(3), 1996, pp. 537-543
Authors:
FAVRE D
CRYZ SJ
VIRET JF
Citation: D. Favre et al., CONSTRUCTION AND CHARACTERIZATION OF A POTENTIAL LIVE ORAL CARRIER-BASED VACCINE AGAINST VIBRIO-CHOLERAE O139, Infection and immunity, 64(9), 1996, pp. 3565-3570
Authors:
KOLLARITSCH H
FURER E
HERZOG C
WIEDERMANN G
QUE JU
CRYZ SJ
Citation: H. Kollaritsch et al., RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF COMBINED SALMONELLA-TYPHI TY21A AND VIBRIO-CHOLERAE-CVD 103-HGR LIVE ORAL VACCINES, Infection and immunity, 64(4), 1996, pp. 1454-1457
Authors:
FAVRE D
CRYZ SJ
VIRET JF
Citation: D. Favre et al., DEVELOPMENT OF SHIGELLA-SONNEI LIVE ORAL VACCINES BASED ON DEFINED RFB(INABA) DELETION MUTANTS OF VIBRO-CHOLERAE EXPRESSING THE SHIGELLA SEROTYPE-D O-POLYSACCHARIDE, Infection and immunity, 64(2), 1996, pp. 576-584
Authors:
JOHANSEN HK
HOUGEN HP
CRYZ SJ
RYGAARD J
HOIBY N
Citation: Hk. Johansen et al., VACCINATION PROMOTES TH1-LIKE INFLAMMATION AND SURVIVAL IN CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA IN RATS, American journal of respiratory and critical care medicine, 152(4), 1995, pp. 1337-1346
Authors:
CRYZ SJ
Citation: Sj. Cryz, IMMUNIZATION AGAINST SALMONELLA-TYPHI, Infectious diseases in clinical practice, 4(6), 1995, pp. 473-474
Authors:
RUBINSTEIN A
GOLDSTEIN H
PETTOELLOMANTOVANI M
MIZRACHI Y
BLOOM BR
FURER E
ALTHAUS B
QUE JU
HASLER T
CRYZ SJ
Citation: A. Rubinstein et al., SAFETY AND IMMUNOGENICITY OF A V3 LOOP SYNTHETIC PEPTIDE CONJUGATED TO PURIFIED PROTEIN DERIVATIVE IN HIV-SERONEGATIVE VOLUNTEERS, AIDS, 9(3), 1995, pp. 243-251
Authors:
WILDE H
GLUECK R
KHAWPLOD P
CRYZ SJ
TANTAWICHIEN T
THIPKONG P
CHOMCHEY P
PRAKONGSRI S
BENJAVONGKULCHAI M
SUMBOONANONDHA A
SAMRANWETAYA P
SUPAKORN K
SITPRIJA V
Citation: H. Wilde et al., EFFICACY STUDY OF A NEW ALBUMIN-FREE HUMAN-DIPLOID CELL RABIES VACCINE (LYSSAVAC-HDC, BERNA) IN 100 SEVERELY RABIES-EXPOSED THAI PATIENTS, Vaccine, 13(6), 1995, pp. 593-596
Authors:
CRYZ SJ
QUE JO
CROSS AS
FURER E
Citation: Sj. Cryz et al., SYNTHESIS AND CHARACTERIZATION OF A POLYVALENT ESCHERICHIA-COLI O-POLYSACCHARIDE TOXIN-A CONJUGATE VACCINE, Vaccine, 13(5), 1995, pp. 449-453
Authors:
POOVORAWAN Y
THEAMBOONLERS A
CHUMDERMPADETSUK S
GLUCK R
CRYZ SJ
Citation: Y. Poovorawan et al., SAFETY, IMMUNOGENICITY, AND KINETICS OF THE IMMUNE-RESPONSE TO A SINGLE-DOSE OF VIROSOME-FORMULATED HEPATITIS-A VACCINE IN THAIS, Vaccine, 13(10), 1995, pp. 891-893
Authors:
CRYZ SJ
GOLDSTEIN H
PETTOELLOMANTOVANI M
KIM A
FURER E
QUE JU
HASLER T
RUBINSTEIN A
Citation: Sj. Cryz et al., HUMAN-IMMUNODEFICIENCY-VIRUS-1 PRINCIPAL NEUTRALIZING DOMAIN PEPTIDE-TOXIN-A CONJUGATE VACCINE, Vaccine, 13(1), 1995, pp. 67-71
Authors:
TACKET CO
LOSONSKY G
NATARO JP
WASSERMAN SS
CRYZ SJ
EDELMAN R
LEVINE MM
Citation: Co. Tacket et al., EXTENSION OF THE VOLUNTEER CHALLENGE MODEL TO STUDY SOUTH-AMERICAN CHOLERA IN A POPULATION OF VOLUNTEERS PREDOMINANTLY WITH BLOOD-GROUP ANTIGEN-O, Transactions of the Royal Society of Tropical Medicine and Hygiene, 89(1), 1995, pp. 75-77
Authors:
CRYZ SJ
QUE JU
LEVINE MM
WIEDERMANN G
KOLLARITSCH H
Citation: Sj. Cryz et al., SAFETY AND IMMUNOGENICITY OF A LIVE ORAL BIVALENT TYPHOID-FEVER (SALMONELLA-TYPHI TY21A) CHOLERA (VIBRIO-CHOLERAE CVD 103-HGR) VACCINE IN HEALTHY-ADULTS, Infection and immunity, 63(4), 1995, pp. 1336-1339
Authors:
JOHANSEN HK
CRYZ SJ
HOIBY N
Citation: Hk. Johansen et al., CLEARANCE OF PSEUDOMONAS-AERUGINOSA FROM NORMAL RAT LUNGS AFTER IMMUNIZATION WITH SOMATIC ANTIGENS OR TOXIN-A, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(7), 1994, pp. 545-553
Authors:
RUBINSTEIN A
GOLDSTEIN H
PETTOELLOMANTOVANI M
CRYZ SJ
Citation: A. Rubinstein et al., PRELIMINARY-RESULTS OF V3 LOOP PEPTIDE-PRIMARY NEUTRALIZING DOMAIN CONJUGATE PHASE-1 VACCINE TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000149-190000153